The device stands at Cosmoprof Asia have changed what they lead with. A few cycles ago the headline was the hardware: diode count, wavelength list, irradiance. This year a large share of exhibitors put app connectivity and progress tracking on the front panel and left the optical specification to the spec sheet.
That is a positioning shift rather than a technology one, and it tells a sourcing buyer more about where the category is going than any single product on the floor.
The Wavelength Spec and What It Buys
Most current devices in this class combine three bands. Blue around 415nm is aimed at acne-associated bacteria. Red around 630nm targets collagen-related pathways. Near-infrared in the 830 to 850nm range penetrates further and is positioned around repair and regeneration.
The specification is easy to read and easy to overstate. Wavelength alone does not determine outcome — irradiance at the skin surface, distance from the emitter, and session duration all matter, and two devices quoting identical wavelengths can deliver very different doses. A buyer comparing units should ask for irradiance figures and the measurement distance they were taken at, because that is where the meaningful difference between a cheap panel and a serious one sits.
Brightening claims deserve the most scrutiny. Manufacturers cite studies, outcomes vary considerably across skin types and usage patterns, and the mechanism is less settled than the marketing implies. A brand building a home-use brightening device around that claim is taking on a substantiation burden it should price in from the start.
Where the Regulatory Line Sits
Light-emitting beauty devices occupy an awkward regulatory position. Depending on the market and the claims made, the same unit can be sold as a general consumer product or fall into a medical device classification with a registration path attached.
Claim language drives the outcome more than the hardware does. Describing a device as supporting skin appearance is a different regulatory proposition from describing it as treating a condition, and brands routinely draft copy that pushes across the line without realising it. Eye safety adds a second layer: sustained high-intensity exposure near the eyes is the risk regulators focus on, and built-in timers, shielded eye zones, and automatic shut-off are increasingly expected rather than optional.
The same logic applies across the home device category generally. Anyone who has taken an at-home light-based device through market entry will recognise the pattern: the engineering is the easy part, and the claim wording is where timelines slip.
Why Connectivity Became the Headline
App connectivity is not there because users asked for another app. It exists to solve a retention problem specific to this category.
Results from light therapy are gradual and hard to perceive day to day. A user who buys a device, uses it four times, sees nothing dramatic, and puts it in a drawer is a churned customer who will not recommend the product. Session logging, streak tracking, and before-and-after capture give the user something observable while the actual effect, if any, accumulates.
From a brand’s perspective the app also collects usage data that nothing else in the range produces. Knowing that median session frequency is twice a week rather than the five times the instructions specify changes what the marketing should say and what the next product should be.
The cost is real. An app means firmware, a support burden, a privacy policy, and an ongoing maintenance commitment that outlasts the hardware warranty. Small brands consistently underestimate the third and fourth of those.
“Walking the floor at a show like Cosmoprof, what stands out to us on the marketing side isn’t just the LED specs. It’s how many exhibitors are now leading with app connectivity and progress tracking as the headline feature. Buyers sourcing beauty devices are increasingly expecting a ‘device plus regimen’ story: the mask paired with a serum or cream line, data that shows the user something is happening. That bundling expectation is reshaping how we brief device launches with clients, well beyond the hardware itself.” — Hyejin Cho, Digital Marketing Specialist, Marketing and Communication Team at SPSCOS
The Device Plus Regimen Bundle
Pairing a device with a topical line is now close to standard, and the commercial logic is straightforward: hardware is a one-time purchase with a long replacement cycle, while a serum or cream is consumable revenue.
The formulation logic is less straightforward. A product intended for use with light therapy has genuine constraints. Photosensitising ingredients are the obvious exclusion. Occlusive textures that sit on the surface can interfere with light reaching the skin, which argues for a thin, fast-absorbing pre-treatment rather than a rich cream. Post-session products face the opposite brief, since the skin may be warm and slightly dry.
Traditional brightening actives such as licorice extract and pearl powder appear frequently in these paired lines, partly for their own merits and partly because they carry a heritage story the hardware cannot. Those choices come with their own compliance work — ingredient sourcing for brightening formulas has drawn regulatory attention over undeclared substances, and a brand attaching a topical to a device inherits that scrutiny alongside the device’s own.
Sourcing Questions Worth Asking First
A brand entering this category through a contract manufacturer should get answers to a short list before committing to tooling.
- Irradiance per band at a stated distance, with the measurement method.
- Which safety certifications the unit already holds, and which are the brand’s responsibility in each target market.
- Who owns and maintains the app, and what happens to it if the relationship ends.
- Battery and diode expected life, since a mask that dims after eighteen months generates warranty cost the margin did not anticipate.
- Whether the housing can be tooled to the brand’s design or is a shared platform with cosmetic changes only.
That last question decides more than it appears to. A shared platform gets a brand to market quickly and cheaply, which is the right call for a first device. It also means the competing product two stands over at the next Cosmoprof is the same unit in a different colour, and the differentiation has to live entirely in the app, the regimen, and the story around them.
Which is, more or less, what the exhibitors leading with connectivity have already worked out.
